Overexpression of AP-2α in pancreatic cancer cells was shown to reduce tumor growth through an altered expression pattern of cell cycle-controlling factors such as CDK-4, CDK-6, Cyclin-G1, p27kip1 and p57kip2[22]. This evidence concerns the gene CDKN1B and familial pancreatic carcinoma.